Chemicals And Allied Products - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Chemicals industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Chemicals And Allied Products - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Chemicals And Allied Products
Corporate Insider Buy Sell Ratio (Insider Count) - Chemicals And Allied Products
Chemicals And Allied Products - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-09-18 ESI / Element Solutions Inc 4 Gliklich Benjamin M - Exercise D 7.95 20,637
2025-09-18 CCCC / C4 Therapeutics, Inc. 4 Adams Kendra F - Taxes D 3.32 -2,775
2025-09-18 ARQ / Arq, Inc. 4 Williamson Jeremy F - Taxes D 7 -2,029
2025-09-17 GEVO / Gevo, Inc. 4 Bloom Paul D S - Sale D 2.0058 -75,000
2025-09-17 LVTX / LAVA Therapeutics N.V. 4 Versant Venture Capital VI, L.P. S - Sale I 1.4892 -226,726
2025-09-17 ELF / e.l.f. Beauty, Inc. 4 MARCHISOTTO KORY S - Sale D 150 -10,812
2025-09-17 LVTX / LAVA Therapeutics N.V. 4 Versant Venture Capital VI, L.P. S - Sale D 1.4892 -362,806
2025-09-17 ELVN / Enliven Therapeutics, Inc. 4 Kintz Samuel S - Sale I 19.0946 -5,000
2025-09-17 KYMR / Kymera Therapeutics, Inc. 4 Jacobs Bruce N. S - Sale D 50.0048 -79,220
2025-09-17 ELF / e.l.f. Beauty, Inc. 4 FIELDS MANDY J S - Sale D 150.2073 -5,298
2025-09-17 ESPR / Esperion Therapeutics, Inc. 4 Halladay Benjamin S - Sale D 2.808 -7,046
2025-09-17 ESPR / Esperion Therapeutics, Inc. 4 Looker Benjamin S - Sale D 2.804 -6,267
2025-09-17 ESI / Element Solutions Inc 4 Liebowitz Matthew S - Sale D 26.55 -50,000
2025-09-17 ESPR / Esperion Therapeutics, Inc. 4 Koenig Sheldon L. S - Sale D 2.788 -28,427
2025-09-17 BYSI / BeyondSpring Inc. 4 Decheng Capital China Life Sciences USD Fund III, L.P. By Decheng Capital China Life Sciences USD Fund III, L.P. S - Sale I 1.83 -2,304
2025-09-17 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 399.9702 -3,135
2025-09-17 ELF / e.l.f. Beauty, Inc. 4 Milsten Scott S - Sale D 150.2285 -15,000
2025-09-17 ALZN / Alzamend Neuro, Inc. 4 AULT MILTON C III By Ault Lending, LLC S - Sale I 2.4535 -2,121
2025-09-17 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 400.9021 -865
2025-09-17 AWHL / Aspira Women's Health Inc. 4 cohen Jeffrey k By HealthView Asset Management P - Purchase I 0.45 55,556
2025-09-17 AWHL / Aspira Women's Health Inc. 4 SCHULER JACK W By Jack W. Schuler Living Trust P - Purchase I 0.45 1,111,111
2025-09-17 AWHL / Aspira Women's Health Inc. 4 Fraser John D P - Purchase D 0.45 16,389
2025-09-17 IMMX / Immix Biopharma, Inc. 4 Rachman Ilya M P - Purchase D 2.02 2,500
2025-09-17 ALXO / ALX Oncology Holdings Inc. 4 Lettmann Jason P - Purchase D 1.0805 71,163
2025-09-17 KYMR / Kymera Therapeutics, Inc. 4 Jacobs Bruce N. M - Exercise D 2.08 79,220
2025-09-17 PGEN / Precigen, Inc. 4 KIRK RANDAL J by R.J. Kirk DOT M - Exercise I 17,385,257
2025-09-17 NRIX / Nurix Therapeutics, Inc. 4 GREGORY JULIA P M - Exercise D 1.86 10,750
2025-09-17 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A M - Exercise D 120.26 4,000
2025-09-17 CRSP / CRISPR Therapeutics AG 4 Kulkarni Samarth G - Gift D -6,000
2025-09-17 ALZN / Alzamend Neuro, Inc. 4 AULT MILTON C III By Ault Lending, LLC C - Conversion I 2.32 100,000
2025-09-17 CGC / Canopy Growth Corporation 4 Stewart Thomas Carlton A - Award D 178,462
2025-09-16 RVMD / Revolution Medicines, Inc. 4 Kelsey Stephen Michael S - Sale D 45.8249 -5,367
2025-09-16 BYSI / BeyondSpring Inc. 4 Decheng Capital China Life Sciences USD Fund III, L.P. By Decheng Capital China Life Sciences USD Fund III, L.P. S - Sale I 1.88 -840
2025-09-16 AXSM / Axsome Therapeutics, Inc. 4 Jacobson Mark L. S - Sale D 116.19 -5,783
2025-09-16 ELF / e.l.f. Beauty, Inc. 4 Franks Joshua Allen S - Sale D 145 -7,913
2025-09-16 RVMD / Revolution Medicines, Inc. 4 Horn Margaret A S - Sale D 45.8249 -4,775
2025-09-16 TNGX / Tango Therapeutics, Inc. 4 Third Rock Ventures IV, L.P. S - Sale D 7.04 -363,541
2025-09-16 VSTM / Verastem, Inc. 4 Paterson Dan S - Sale D 9.99 -390
2025-09-16 CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) 4 Accardi Mario Alberto S - Sale D 22.0213 -742
2025-09-16 AXSM / Axsome Therapeutics, Inc. 4 Jacobson Mark L. S - Sale D 114.23 -40,000
2025-09-16 CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) 4 Accardi Mario Alberto S - Sale D 21.3333 -7,430
2025-09-16 SRRK / Scholar Rock Holding Corporation 4 Qatanani Mo S - Sale D 33.5200 -3,178
2025-09-16 APLS / Apellis Pharmaceuticals, Inc. 4 Watson David O. S - Sale D 24.34 -5,000
2025-09-16 SRRK / Scholar Rock Holding Corporation 4 Peng Katie S - Sale D 32.4761 -930
2025-09-16 MNKD / MannKind Corporation 4 Tross Stuart A S - Sale D 5.34 -47,000
2025-09-16 VSTM / Verastem, Inc. 4 Stuglik Brian M S - Sale D 9.99 -587
2025-09-16 RVMD / Revolution Medicines, Inc. 4 Wei Lin S - Sale D 45.8249 -2,160
2025-09-16 SRRK / Scholar Rock Holding Corporation 4 Peng Katie S - Sale D 33.1963 -76
2025-09-16 ONC / BeOne Medicines AG - Depositary Receipt (Common Stock) 4 OYLER JOHN S - Sale D 327.78 -400
2025-09-16 LVTX / LAVA Therapeutics N.V. 4 Versant Venture Capital VI, L.P. S - Sale I 1.5332 -192,293
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)